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the-counter cosmetics has been limited by its high cost and poor storage stability in aqueous 79 environments due to premature swelling and hydrolysis. Premature swelling of hyaluronic acid 80 during storage prior to application can compromise absorption if the hydrated polymer is larger 81 than the size of a skin pore (Pilkington et al., 2015) . Furthermore, pure hyaluronic acid in 82 aqueous cosmetics are susceptible to premature hydrolysis, which leads to lowered moisture 83 retention activity on the skin. For example, Simulescu et al. found that hyaluronic acid of varying 84 sizes were susceptible to 90% weight average molecular weight decreases when stored at room 85 temperature for 2 months without antimicrobials or protectants. Refrigeration limited but did not 86 prevent hydrolysis when in solution (Simulescu et al., 2016) . Mondek found that although the 87 overall hyaluronic acid polydispersity remained unchanged, degradation was attributed to 88 temperature (Mondek et al., 2015) . Molecular weight changes were observed at both room 89 (25°C) and refrigerated (4°C) temperatures. For successful topical hyaluronic acid application, 90 effective strategies for extended storage in aqueous formulations and controlled release on skin 91 are clearly needed. 92
Many have explored encapsulation as a method to protect and deliver hyaluronic acid for 93 medical applications. In a hyaluronic acid preparation for deep dermal drug delivery, Berkó et al. 94 found that chemically cross-linking hyaluronic acid helped to maintain its desirable hydration 95 effect. Even when smaller particles were produced due to the nature of the cross-linking method, 96 there were limited changes to the overall rheolgical properties of hyaluronic acid. These small 97 cross-linked hyaluronic acid particles were able to improve membrane diffusion and skin 98 penetration compared to linear hyaluronic acid (Berkó et al., 2013) . 99
Only a few have attempted to spray dry hyaluronic acid, all with final applications in 100 pharmaceuticals (Iskandar et al., 2009 , Huh et al., 2010 . Cross-linked Alginate Microcapsules 101 (CLAMs) provide a storage method that is capable of incorporating cargo without chemical 102 modification into its matrix and prevents release in water. CLAMs produced by a patented, 103
industrially-scalable, one-step method developed by our research group is pH mediated, where a 104 feed suspension of cargo, encapsulant (alginate), calcium salt, weak acid, and volatile base are 105 spray dried such that gelling, curing and drying occur in situ, Figure 1 , (Jeoh-Zicari et al., 2017) . 106
In contrast, traditional methods for forming CLAMs require multiple time consuming steps that 107 are prohibitively costly to scale up (Strobel et al., 2019a) . Like hyaluronic acid, alginate is also a 108 hydroscopic, polyuronic acid biopolymer with high solution viscosity (Draget and Taylor, 2011) . 109
The resulting CLAMs are water insoluble, maintain barrier properties in storage, and exhibit 110 unique release characteristics. 111
In this study, the encapsulation of hyaluronic acid in CLAMs by spray drying was 112 explored, with the goal of producing dry particles with limited swelling in aqueous storage. 113
Hyaluronic acid was incorporated into the encapsulation matrix of alginate, and the resulting dry 114 hyaluronic acid loaded CLAMs (HA-CLAM) were characterized. Additionally, an alternate 115 CLAMs formulation utilizing pH responsive chelated calcium in the feed was explored. 'Chelate CLAMs' were also formed with and without hyaluronic acid cargo. This 148 variation on the methods outlined above used HV alginate at 0.5% (w/w) in the spray dryer feed 149 formulation. The feed solution was prepared by titrating a solution of phytic acid (inositol 150 hexakisphosphate) to pH 8.4 with ammonium hydroxide. Phytic acid was included in the feed 151 formulation at 5 times the concentration of calcium chloride (0.625% of solution). Hyaluronic 152 acid was incorporated to the chelate solution to achieve 61% dry basis final hyaluronic acid 153 content to be directly compared to previous formulations. 154
Spray dried hyaluronic acid particles were formed with calcium hydrogen phosphate to 155 assess the ability of hyaluronic acid to participate in ion-mediated cross-linking. Solutions were 156 prepared with 2% (w/w) hyaluronic acid and twice the concentration of succinic acid. Succinic 157 acid was titrated to pH 5.6 with ammonium hydroxide to prevent the solubility of calcium 158 hydrogen phosphate which was included at 0.25% (w/w) in solution. All formulations were 159 prepared at a 2:1 ratio of alginate or hyaluronic acid to succinic acid and an 8:1 ratio of polymer 160 to calcium. All the variations of the CLAMs tested in this study are summarized in Table 1 . 
Monitoring Hyaluronic Acid Release in Water 182
Hyaluronic acid release from HA-CLAMs in water was monitored over 120 min. Both 183 empty CLAMs and HA-CLAMs were suspended at 1% (w/v) in water in separate tubes for each 184 timed point. Samples were analyzed for hyaluronic acid release at 0, 15, 30, 45, 60, 90, and 120 185 min after continuous rotation at 25 rpm. Two minutes prior to the predetermined time, samples 186 were centrifuged at 5000 rpm for 2 min to separate residual solid CLAMs from the supernatant. 
198
Empty CLAMs served as controls in all release measurements. 199 The Schiff's reagent does not react with hyaluronic acid and is therefore specific to 224 alginate quantitation when both alginates and hyaluronic acids are present in solution. 225
Determining the extent of Cross-linking of CLAMs -Periodic Schiff's Fuchsin

Carbazole Assay for Uronic Acid Quantitation 226
The carbazole assay measures total uronic acids in solution (Bitter and Muir, 1962, 227 Blumenkrantz Testing Lab at the University of California, Davis. 244
Quantifying the Water Absorption Capacity (WAC) and Plumping Ratio of the 245
cross-linked microparticles in water 246
Water Absorption Capacity (WAC), the mass ratio of a hydrated product compared to its 247 dry counterpart, indicates the extent to which the cross-linked microparticles (with and without 248 hyaluronic acid) uptake water. The plumping ratio, i.e. the volume ratio of hydrated product 249 compared to its dry counterpart, is a measure of the product volume change due to absorption of 250 water. Plumping indicates the extent to which the cross-linked microparticles (with and without 251 hyaluronic acid) swell upon water absorption. 252 Dry powder samples (Table 1) (0.1 g) were added to 2 g of DI water in 13 x 100 flat bottom 253 glass test tubes and allowed to sit for 45 min at room temperature. After 45 min, the test tubes 254 were centrifuged at 190 g for 3 min in a swinging bucket centrifuge. The separated supernatant 255 was removed and weighed. The mass of the hydrated powder was determined from the 256 difference between the mass of the dry powder and added water (2.1 g) and the mass of the 257 supernatant. The hydrated product height was measured using calipers. 258
The WAC was calculated as follows: 259
The height difference between dry and hydrated product was used to determine the 261 plumping ratio in water. 262 process parameter, spray-dryer feed viscosities modulated by the alginate source has been shown 292 to impact CLAMs properties (Strobel, 2017) . In this study, two commercially sourced alginates 293 were compared on the basis of the resulting viscosities when dissolved in water (high viscosity 294
(HV) and low viscosity (LV) alginates). 295
The formation of CLAMs uses a calcium salt such as calcium hydrogen phosphate that is 296 largely insoluble at the pH in the spray dryer feed, and only solubilizes upon volatilization of 297 ammonia to drop the pH when the feed is atomized (Jeoh-Zicari et al., 2012). In a recent study 298 however, we found that calcium concentrations maximizing cross-linking can leave residual 299 insoluble calcium in the final CLAMs product (Strobel et al., 2019b) . The presence of insoluble 300 calcium salts could decrease the quality of consumer products such as topical creams; thus, an 301 alternate process was developed to use a soluble calcium salt such as calcium chloride instead. In 302 this formulation, soluble calcium in the spray dryer feed is sequestered by an acidic chelator to 303 prevent premature cross-linking. Ammonia vaporization when the feed is atomized reduces the 304 pH below the pKa of the chelator to protonate the chelator and release calcium ions that 305 subsequently cross-link the alginates. CLAMs formed with chelated calcium (i.e. 'Chelate 306
CLAMs') thus do not contain residual insoluble calcium salts. 307
For all variations, CLAMs without cargo ('Empty CLAMs') and containing 61 % (d.b.) 308 hyaluronic acid as cargo ('HA-CLAMs') were formulated with the same calcium content in the 309 final product. Additionally, cross-linked HA microparticles formed by the CLAMs process with 310 no alginates were produced to test the ability of hyaluronic acid alone to effectively cross-link 311 calcium. The seven variations of microcapsules/particles generated in this study are summarized 312
in Table 1 . 313
Physical characterization of dry cross-linked microcapsules 314
Spray-dried CLAMs containing no cargo (i.e Empty CLAMs, Table 1 ) exhibit a 'bowl' 315 morphology as shown in Figure 1a The SEMs suggest that the particles in all the samples range between ~ 1 -10 µm in size. 333
The measured size distributions, however, show broad distributions centered at ~ 10 -80 µm, 334 reflecting the tendency of the particles to aggregate in isopropanol (Figure 3) . Despite efforts to 335 break up aggregates by vigorous mixing and sonication, particle aggregation in isopropanol 336 persisted. Sizing in water was not attempted because of the potential for swelling and dissolution 337 discussed in the following sections. Samples were measured in isopropanol to prevent particle swelling. 345 346
Characterization of cross-linked microcapsules in water 347
In addition to being biocompatible and non-immunogenic, hyaluronic acid has a high 348 affinity for water; water-uptake and retention is useful in many medical and dermal 349 applications. The water absorption capacity (WAC) of water-absorptive polymers such as 350 hyaluronic acid is commonly used to evaluate the ingredient efficacy by the dermal cosmetics 351 industry (Zhao, 2006 , Liu and Rempel, 1997 , Kiatkamjornwong, 2007 , Bencherif et al., 2008 . 352 Additionally, 'plumping ratio', an in tubo measurement of product volume change, indicates the 353 extent to which hydrogels swell with water uptake, a favorable attribute of hyaluronic acid. In 354 this study, however, hyaluronic acid was microencapsulated with the goal of minimizing water 355 uptake and swelling during aqueous storage to extend its shelf-stability in water. provided in Table 1 with lower case letters representing statistical differences for either WAC or  373 Plumping; n = 4. 374 375 Some differences were noted when either LV or HV alginates were used in the CLAMs. 376
CLAMs formed with the higher viscosity alginates (HV Empty CLAMs and HV HA-CLAMs) 377 had higher WACs than those formed with the lower viscosity alginates (LV Empty CLAMs and 378 LV HA-CLAMs) (Figure 4a ). The differences between the LV and HV alginates are likely due to 379 molecular weight differences and in the molecular arrangements of the guluronic (G) and 380 mannuronic (M) acid residues. Further characterization of these alginates and their influence of 381
CLAMs properties is on-going. The type of alginates, however, had no significant influence on 382 the plumping ratios (Figure 4b) . 383
The method of CLAMs formation also had some influence on the water interaction 384
properties of the CLAMs. Chelate Empty CLAMs that were formed by releasing chelated 385 calcium during spray drying had a higher WAC but lower plumping ratio than HV Empty 386 CLAMs formed by solubilizing calcium hydrogen phosphate during spray drying (Figure 4) . 387
Including the hyaluronic acid cargo to form Chelate HA-CLAMs resulted in a 2.4-fold decrease 388 in WAC and a ~ 0.4-fold decrease in plumping ratio of Chelate CLAMs. 389
The results in Figure 4 suggest that microencapsulation of hyaluronic acid in CLAMs can 390 limit water uptake and swelling of the product; however, these measurements did not account for 391 any dissolution of the microcapsules and release of hyaluronic acid during incubation in water. conditions (e.g. solids loading and inlet temperature (Strobel, 2017) ). In this study, higher 403 viscosity alginates resulted in more extensively cross-linked CLAMs than the lower viscosity 404 alginates; HV Empty CLAMs were 87 ± 1 % cross-linked while LV Empty CLAMs were 75 ± 3 405 % cross-linked (Table 1) . Loading hyaluronic acid as cargo did not significantly impact cross-406 linking in the CLAMs; HV HA-CLAMs were 71 ± 13 % cross-linked compared to 80 ± 7 % 407 cross-linked LV HA-CLAMs. For HA-CLAMs, choosing the higher viscosity alginates did not 408 improve cross-linking. In contrast, hyaluronic acid as cargo appeared to significantly affect 409 cross-linking in the CLAMs formed with chelated calcium, where Chelate Empty CLAMs were 410 82 ± 4 % cross-linked, while Chelate HA-CLAMs were only 55 ± 9 % cross-linked. 411
The extent of cross-linking of CLAMs was previously shown to influence retention of cargo 412 in water (Strobel et al., 2019b) . To assess the kinetics of alginate and hyaluronic acid release 413 during storage, the cross-linked microparticles were suspended in water and monitored over 120 414 min ( Figure 5 ). Non-cross-linked alginates in all CLAMs formulation dissolved within the first 415 15 min, and the extent of dissolution was consistent with measured extents of cross-linking 416 (Table 1) In contrast to previous observations with dextran-loaded CLAMs (30), CLAMs 434 containing hyaluronic acid did not fully release the cargo after 2 hours. One reason for this 435 difference may be because hyaluronic acid could form calcium mediated cross-links within the 436 CLAMs matrix whereas dextrans lack charged groups along the polymer backbone for 437 electrostatic interactions. The potential for hyaluronic acid alone to form insoluble, cross-linked 438 microparticles was examined by forming Cross-linked HA microparticles (Table 1, Figure 5d ). 439
In water, ~ 20 % of the Cross-linked HA Microparticles dissolved immediately, indicating that 440 this fraction was not cross-linked within the microparticles. A nearly linear dissolution of 441 hyaluronic acid was observed in the first 45 minutes in water, and only 11 % remained cross-442 linked and insoluble after 2 hours. Hyaluronic acid alone dissolves completely upon addition to 443 water. Thus, the relatively slow release of hyaluronic acid from the Cross-linked HA 444
Microparticles suggests that the polymer was likely cross-linked within the microparticles; 445 ultimately, the near complete dissolution, however, indicates that the cross-linking was weak and 446 could be disrupted in water. Comparing the gradual but nearly complete release kinetics of 447 hyaluronic acid from the Cross-linked HA Microparticles to that of rapid but incomplete release 448 from CLAMs (Figure 5a Chelate HA-CLAMs limited hyaluronic acid release to less than 22 ± 9 % within the 2-hour 459 period, in contrast to up to ~ 72 % from HV HA-CLAMs. Contrary to previous findings, the 460 extent of alginate cross-linking in the Chelate CLAMs did not correlate with cargo retention as 461 the alginates in Chelate HA-CLAMs were significantly less cross-linked than in Chelate Empty 462
CLAMs (Table 1) . 463
CLAMs were stored for 12 months at 1% (w/v) in deionized water at 4°C. Hydrated 464 particles were visible to the eye, could be suspended upon physical disturbance and settled out of 465 solution over time ( Figure 6 ). There were clear differences in the persistence of insoluble 466 particles between the different formulations. Turbidity in the LV and HV HA-CLAMs 467 suspensions indicated residual insoluble particles. Individual, hydrated particles could be 468 observed in the HV HA-CLAMs and Chelate HA-CLAMs suspensions after the extended storage 469 period. Thus, CLAMs show potential to remain cross-linked during storage in aqueous 470 formulations like those of cosmetics until release is triggered by the addition of chelators that 471 will dissociate the calcium cross-links. 472 473 474 475 Figure 6 : HA-CLAMs after storage in water at 4°C for 12 months (1% w/v). 476 477 478
CONCLUSIONS 479
CLAMs successfully carried hyaluronic acid after in situ cross-linking with calcium 480 during spray-drying. HA-CLAMs in water retained up to half the cargo even after 2 hours, 481
suggesting that hyaluronic acid participates in calcium cross-linking within the CLAMs particles. 482
Further, hyaluronic acid in CLAMs significantly decreased particle swelling and water uptake in 483 aqueous environments, an advantage for incorporation of these microparticles in water-based 484 topical cream formulations. 485
To address the problem of residual insoluble calcium in cosmetics products, a new 486
Chelate CLAMs formulation was evaluated in comparison to the state of the art CLAMs. Chelate 487 CLAMs had similar physical attributes, but far outperformed in retaining hyaluronic acid in 488 water during storage. Hyaluronic acid participates in calcium mediated cross-linking in the 489 microparticles, blurring the line between cargo and matrix material. This expands the technology 490 capability and possible applications due to increased potential for using polyuronic acids as 491 reinforcement in CLAMs while maintaining characteristic triggered release capabilities. In situ 492 cross-linking facilitated by pH mediated calcium solubility during spray drying was still 493 successful with this matrix variation. 494
Physical characterization and release data support the notion that biopolymer active cargo 495 can contribute to the tailored application of microencapsulation methods to improve release and 496 barrier properties. Hyaluronic acid incorporation is not limited to CLAMs and can reasonably be 497 tested for hydrogels, foams, and many material dispersions. Further implications of enhanced 498 release control with a mixed CLAMs matrix include improved toggling of storage and release for 499 pharmaceutical, medical, food, and whole host of applications where fine tuning is imperative. 500 501 ACKNOWLEDGEMENTS 502 503
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